Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Cannabinoid receptor as a novel target for the treatment of prostate cancer.

Sarfaraz S, Afaq F, Adhami VM, Mukhtar H.

Cancer Res. 2005 Mar 1;65(5):1635-41.

2.

Cannabinoids in the treatment of cancer.

Alexander A, Smith PF, Rosengren RJ.

Cancer Lett. 2009 Nov 18;285(1):6-12. doi: 10.1016/j.canlet.2009.04.005. Epub 2009 May 12. Review.

PMID:
19442435
3.
4.

Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.

Ashton JC, Wright JL, McPartland JM, Tyndall JD.

Curr Med Chem. 2008;15(14):1428-43. Review.

PMID:
18537620
5.

Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.

Pertwee RG.

Life Sci. 2005 Feb 4;76(12):1307-24. Epub 2004 Dec 8. Review.

PMID:
15670612
6.

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

McAllister SD, Soroceanu L, Desprez PY.

J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Epub 2015 Apr 28. Review.

7.

[Research progress of role of cannabinoid receptor in fibrosis].

Li S, Wang L, Liu M, Gao Y, Tian Z, Jiang S, Zhang M, Guan D.

Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):136-8. Review. Chinese. No abstract available.

PMID:
24742582
8.

Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists.

Greineisen WE, Turner H.

Int Immunopharmacol. 2010 May;10(5):547-55. doi: 10.1016/j.intimp.2010.02.012. Epub 2010 Feb 25. Review.

9.

Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulation.

Picone RP, Kendall DA.

Mol Endocrinol. 2015 Jun;29(6):801-13. doi: 10.1210/me.2015-1062. Epub 2015 Apr 13. Review.

10.

Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?

Giaginis C, Lakiotaki E, Korkolopoulou P, Konstantopoulos K, Patsouris E, Theocharis S.

Curr Med Chem. 2016;23(22):2350-62. Review.

PMID:
27237820
11.

Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review).

Dobovišek L, Hojnik M, Ferk P.

Int J Mol Med. 2016 Dec;38(6):1642-1651. doi: 10.3892/ijmm.2016.2779. Epub 2016 Oct 17. Review.

PMID:
27779654
12.

[Future medications for tobacco and cannabis dependence].

Le Foll B, Justinova Z, Tanda G, Goldberg SR.

Bull Acad Natl Med. 2008 Jan;192(1):45-56; discussion 56-7. Review. French.

13.

Critical appraisal of the potential use of cannabinoids in cancer management.

Cridge BJ, Rosengren RJ.

Cancer Manag Res. 2013 Aug 30;5:301-13. doi: 10.2147/CMAR.S36105. eCollection 2013. Review.

Supplemental Content

Support Center